Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new
Vol. 6, Issue 5 (2017)

Clinical evaluation of 0, 2% hyaluronic acid containing gel “gengigel” in the local treatment of pregnant women with generalized periodontitis on the background of IDA

Author(s):
Boychuk-Tovsta OG and Rozhko MM
Abstract:
State of the oral cavity during pregnancy has attracted the attention of many researchers as periodontal and tooth diseases can cause "dental chronioseptic source of inflammation." It was discovered that pregnant women with extragenital diseases, including hematologic, increase the likelihood of periodontal lesions. One of the most important factors in the pathogenesis of periodontal tissue diseases is inflammation that develops in response to an irritant of pathogenic microflora of periodont and causes complex microcirculatory, hematological, immunological and connective tissue reactions.We reliably established high efficiency of "Gengigel" (Racerfarma s.r.l., Italy) in treatment of patients with generalized periodontitis of pregnant women with IDA. Using clinical methods of examination, pronounced anti-inflammatory and regenerative properties of the drug were confirmed when applied locally to the oral mucosa. A local treatment of generalized periodontitis in pregnant women with IDA in the background with preparation "Gengigel" is suggested.
Pages: 79-81  |  877 Views  30 Downloads
How to cite this article:
Boychuk-Tovsta OG, Rozhko MM. Clinical evaluation of 0, 2% hyaluronic acid containing gel “gengigel” in the local treatment of pregnant women with generalized periodontitis on the background of IDA. Pharma Innovation 2017;6(5):79-81.
The Pharma Innovation Journal